---
title: 'The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493
  Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither
  Increased Risks of Kidney Stones nor Atherosclerosis'
date: '2024-07-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39064694/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240727183108&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: Potential calcium-related adverse events of vitamin D supplement
  use have not been addressed in large-scale, real-world data so far. Methods: Leveraging
  data from the UK Biobank, encompassing 445,493 individuals aged 40-69, we examined
  associations of high 25-hydroxyvitamin (25(OH)D) levels ≥ 100 nmol/L and vitamin
  D supplementation with hypercalcemia (serum calcium > 2.6 mmol/L), kidney stones,
  and atherosclerosis assessments (pulse wave arterial stiffness index and ...'
disable_comments: true
---
Background: Potential calcium-related adverse events of vitamin D supplement use have not been addressed in large-scale, real-world data so far. Methods: Leveraging data from the UK Biobank, encompassing 445,493 individuals aged 40-69, we examined associations of high 25-hydroxyvitamin (25(OH)D) levels ≥ 100 nmol/L and vitamin D supplementation with hypercalcemia (serum calcium > 2.6 mmol/L), kidney stones, and atherosclerosis assessments (pulse wave arterial stiffness index and ...